• Targeted SPP1 Inhibition in Tumor-Associated Macrophages: St

  2026-05-19

  A recent study demonstrates that direct targeting of SPP1 in tumor-associated macrophages (TAMs) via small molecule modulators and a TAM-specific nanoformulation can significantly reduce tumor burden in murine models. These findings provide a mechanistic foundation for developing new macrophage-directed therapies that modulate the tumor microenvironment and improve cancer treatment outcomes.

• Solving Lab Challenges with EZ Cap™ Cas9 mRNA (m1Ψ): Workflo

  2026-05-18

  This article examines real laboratory scenarios where EZ Cap™ Cas9 mRNA (m1Ψ) (SKU R1014) addresses common pain points in genome editing workflows. Drawing on published data and validated workflow recommendations, it illustrates how the Cap1 structure and m1Ψ modification improve editing efficiency, mRNA stability, and immune evasion. The analysis supports reliable protocol design and vendor selection for high-fidelity CRISPR-Cas9 applications.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-05-18

  This study introduces a novel gastric cancer assembloid model that integrates patient-matched tumor organoids and stromal cell subpopulations, better reflecting in vivo tumor heterogeneity. The model enables more accurate drug response profiling and offers a robust platform for studying resistance mechanisms and advancing personalized therapy strategies.

• Septin4 Enhances Hypoxic Cardiomyocyte Injury via HIF-1α Deg

  2026-05-17

  This study reveals that Septin4 exacerbates hypoxia-induced injury in cardiomyocytes by promoting von Hippel-Lindau (VHL)-mediated ubiquitination and degradation of HIF-1α. These mechanistic insights highlight how Septin4 modulates cellular adaptation to hypoxia and suggest potential directions for intervention in ischemic heart disease.

• AP20187 (SKU B1274): Reliable Dimerization for Cell Assays

  2026-05-16

  AP20187 (SKU B1274) is a synthetic, cell-permeable chemical inducer of dimerization, enabling precise and reproducible control of fusion protein activation in gene expression, viability, and metabolic assays. This article delivers scenario-driven guidance for bench scientists, highlighting evidence-backed protocol parameters, data interpretation, and workflow reliability for AP20187 from APExBIO.

• Pepstatin A: Translational Leverage in Aspartic Protease Pat

  2026-05-15

  This thought-leadership article advances the discussion on Pepstatin A by integrating mechanistic insights from cutting-edge necroptosis research, strategic guidance for translational researchers, and evidence-based best practices. Moving beyond the conventional inhibitor narrative, the article frames Pepstatin A as an essential tool for decoding aspartic protease functions in cell death, viral processing, and bone biology, while highlighting the evolving landscape and remaining challenges.

• Dihydrotestosterone (DHT): Optimizing Workflows for Resistan

  2026-05-15

  Dihydrotestosterone (DHT) enables precise modeling of androgen receptor signaling and EGFR/ERBB2 pathway dynamics, supporting advanced research into therapy resistance in cancer and neurodegeneration. This guide translates recent mechanistic advances into actionable protocols and troubleshooting tips, leveraging APExBIO’s DHT as a gold-standard research tool.

• Propidium Iodide: Optimizing DNA Intercalating Dye Workflows

  2026-05-14

  Propidium iodide enables precise viability, apoptosis, and cell cycle analysis by selectively staining cells with compromised membranes. This article bridges the latest research and hands-on troubleshooting to help scientists leverage APExBIO’s PI for robust, reproducible assays.

• CK2α–VP2 Interaction Enables CIAV Replication: Mechanistic I

  2026-05-14

  This study reveals how chicken infectious anemia virus (CIAV) depends on the host kinase CK2α for its replication, mediated by a direct interaction with the viral VP2 protein at specific residues. The findings offer a molecular basis for targeting CK2α as an antiviral strategy in poultry and provide a framework for future research on host-directed antiviral interventions.

• KAS-ATAC Sequencing: Mapping Simultaneously Accessible and s

  2026-05-13

  The reference protocol details KAS-ATAC sequencing, a technique enabling the high-resolution mapping of genomic regions that are both physically accessible and contain single-stranded DNA. This approach leverages specific chemical labeling to bridge chromatin accessibility profiling with direct detection of transcriptional activity, expanding capabilities for regulatory genomics.

• Tackling qPCR Reproducibility: HotStart™ 2X Green Master Mix

  2026-05-13

  This article addresses persistent qPCR challenges—non-specific amplification, workflow inconsistencies, and data reliability—faced by biomedical researchers in cell viability and gene expression studies. Through scenario-driven Q&A, we demonstrate how HotStart™ 2X Green qPCR Master Mix (SKU K1070) delivers robust performance, evidence-backed specificity, and operational consistency, while integrating workflow best practices and literature insights.

• MMP7 Drives EMT and Liver Fibrosis via E-cadherin/β-Catenin

  2026-05-12

  This study clarifies how matrix metalloproteinase 7 (MMP7) promotes liver fibrosis in biliary atresia by inducing epithelial–mesenchymal transition (EMT) through E-cadherin cleavage and β-catenin pathway activation. The findings highlight MMP7 as a mechanistic driver and potential therapeutic target in progressive pediatric liver fibrosis.

• ARCA EGFP mRNA (5-moUTP): Setting New Standards in Polyadeny

  2026-05-12

  Explore how ARCA EGFP mRNA (5-moUTP) redefines polyadenylated mRNA control assays with superior stability, translational efficiency, and reduced innate immune activation. This article delivers a deep technical analysis and practical guidance for advanced fluorescence-based mRNA transfection in mammalian cells.

• Septin4 Accelerates HIF-1α Degradation and Cardiomyocyte Apo

  2026-05-11

  This study uncovers a novel mechanism by which Septin4 enhances cardiomyocyte apoptosis during hypoxia by promoting VHL-mediated degradation of HIF-1α. These findings refine our understanding of oxygen sensing in cardiac injury and suggest new avenues for therapeutic intervention targeting the HIF-1α stability pathway.

• Dibutyryl-cAMP, Sodium Salt: Advanced cAMP Signaling Workflo

  2026-05-11

  Dibutyryl-cAMP, sodium salt (DBcAMP sodium salt) empowers precise, reproducible manipulation of cAMP signaling across diverse cellular models. This guide translates recent systems biology and disease-modeling breakthroughs into actionable protocols and optimization strategies for bench researchers.

639 records 15/43 page Previous Next First page 上5页 1112131415 下5页 Last page